1-6 of 6
David Perol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P1-18-09: Impact of prior adjuvant trastuzumab (aT) on clinical characteristics, patterns of recurrence and outcomes in 4145 patients with Her2 positive (HER2+) metastatic breast cancer (MBC)- Results from the French ESME UNICANCER program

Fanny Le Du, Matthieu Carton, Mahasti Saghatchian, David Perol, Barbara Pistilli, Etienne Brain, Delphine Loirat, Laurence Vanlemmens, Thomas Vermeulin, Christelle Levy, Anthony Goncalves, Mony Ung, Marie Robert, Anne Jaffre, Mathieu Robain, Suzette Delaloge, Véronique Dieras
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-18-09.
https://doi.org/10.1158/1538-7445.SABCS21-P1-18-09
Published: 15 February 2022
View article titled, Abstract P1-18-09: Impact of prior adjuvant trastuzumab (aT) on clinical characteristics, patterns of recurrence and outcomes in 4145 patients with Her2 positive (HER2+) metastatic breast cancer (MBC)- Results from the French ESME UNICANCER program
Journal Articles

Abstract P2-19-01: Impact of bone-only metastatic breast cancer on outcome in a real-life setting: A comprehensive analysis of 5,041 women from the ESME database

Marion Bertho, Julien Fraisse, Anne Patsouris, Paul Cottu, Suzette Delaloge, David Pérol, Anne Jaffré, Anthony Goncalves, Marie-Paule Lebitasy, Véronique D'Hondt, Florence Dalenc, Jean-Marc Ferrero, Christelle Levy, Patrick Arveux, Roman Rouzier, Frédérique Penault-Llorca, Lionel Uwer, Jean-Christophe Eymard, Mathias Breton, Michaël Chevrot, Marianne Leheurteur, Michel Velten, Gaëtane Simon, Jean-Sébastien Frenel
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P2-19-01.
https://doi.org/10.1158/1538-7445.SABCS19-P2-19-01
Published: 15 February 2020
View article titled, Abstract P2-19-01: Impact of bone-only metastatic breast cancer on outcome in a real-life setting: A comprehensive analysis of 5,041 women from the ESME database
Journal Articles

Abstract LB-253: A comprehensive evaluation of immune checkpoints ligands (ICPLs) in more than 1,000 cancer cell lines (CCLs) identifies specific expression patterns

Aurélie Swalduz, Jean-Philippe Foy, Xiaojun Jiang, Roberto Incitti, Sylvie Chabaud, David Pérol, Jean-Yves Blay, Olivier Trédan, Isabelle Treilleux, Aurélien Marabelle, Maurice Pérol, Christophe Caux, Pierre Saintigny
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-253.
https://doi.org/10.1158/1538-7445.AM2014-LB-253
Published: 01 October 2014
View article titled, Abstract LB-253: A comprehensive evaluation of immune checkpoints ligands (ICPLs) in more than 1,000 cancer cell lines (CCLs) identifies specific expression patterns
Journal Articles

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1st line metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Christine Menetrier-Caux, Isabelle Ray-Coquard, Claire Cropet, Estelle Verronese, Thomas Bachelot, Olivier Tredan, Gwenaelle Garin, Pierre Heudel, Axelle N'Kodia, Ana Delgado, Christine Bardin-Dit-Courageot, Chantal Rigal, Gilles Clapisson, Sylvie Chabaud, David Perol, Paul Rebattu, Thérèse Croughs, Nicolas Pasqual, Manuarii Manuel, Michel Morre, Jean-Yves Blay, Christophe Caux
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2574.
https://doi.org/10.1158/1538-7445.AM2014-2574
Published: 01 October 2014
View article titled, Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1<sup>st</sup> line metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number
Journal Articles

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients

Ray-Coquard Isabelle, Olivier Tredan, Gwenaele Garin, Christine Ménétrier-Caux, Sylvie Chabaud, Thomas Bachelot, Claire Cropet, Pierre-Etienne Heudel, Paul Rebattu, Patricia Dupont, Estelle Verronese, Anne-claire Cadore, Valérie Fouillat, Olfa Derbel, Nathalie Bonnin, Thérèse Croughs, Michel Morre, Nicolas Pasqual, Manuari Manuel, Gilles Clapisson, Christophe Caux, David Pérol, Jean-Yves Blay
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT333.
https://doi.org/10.1158/1538-7445.AM2014-CT333
Published: 01 October 2014
View article titled, Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a evaluating the impact of IL-7 immunotherapy on CD4 count, risks of severe haematological toxicity and tumor progression in metastatic breast cancer patients
Journal Articles

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, Catherine Sebban, Axel Le Cesne, Ian Judson, Olivier Tredan, Jaap Verweij, Pierre Biron, Inthidar Labidi, Jean-Paul Guastalla, Thomas Bachelot, David Perol, Sylvie Chabaud, Pancras C.W. Hogendoorn, Philippe Cassier, Armelle Dufresne, Jean-Yves Blay, on behalf of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5383–5391.
https://doi.org/10.1158/0008-5472.CAN-08-3845
Published: 01 July 2009
View article titled, Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Open the PDF for Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas in another window